-
Je něco špatně v tomto záznamu ?
Mitochondria-driven elimination of cancer and senescent cells
S. Hubackova, S. Magalhaes Novais, E. Davidova, J. Neuzil, J. Rohlena,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
30281511
DOI
10.1515/hsz-2018-0256
Knihovny.cz E-zdroje
- MeSH
- adenosindifosfát metabolismus MeSH
- adenosintrifosfát metabolismus MeSH
- biologický transport MeSH
- buněčná smrt MeSH
- lidé MeSH
- mitochondrie metabolismus MeSH
- nádory metabolismus patologie MeSH
- oxidativní fosforylace MeSH
- proliferace buněk MeSH
- reaktivní formy kyslíku metabolismus MeSH
- stárnutí buněk * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Mitochondria and oxidative phosphorylation (OXPHOS) are emerging as intriguing targets for the efficient elimination of cancer cells. The specificity of this approach is aided by the capacity of non-proliferating non-cancerous cells to withstand oxidative insult induced by OXPHOS inhibition. Recently we discovered that mitochondrial targeting can also be employed to eliminate senescent cells, where it breaks the interplay between OXPHOS and ATP transporters that appear important for the maintenance of mitochondrial morphology and viability in the senescent setting. Hence, mitochondria/OXPHOS directed pharmacological interventions show promise in several clinically-relevant scenarios that call for selective removal of cancer and senescent cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045209
- 003
- CZ-PrNML
- 005
- 20200113084738.0
- 007
- ta
- 008
- 200109s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/hsz-2018-0256 $2 doi
- 035 __
- $a (PubMed)30281511
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hubackova, Sona $u Molecular Therapy Group, Institute of Biotechnology, Czech Academy of Sciences, 252 50 Vestec, Prague-West, Czech Republic.
- 245 10
- $a Mitochondria-driven elimination of cancer and senescent cells / $c S. Hubackova, S. Magalhaes Novais, E. Davidova, J. Neuzil, J. Rohlena,
- 520 9_
- $a Mitochondria and oxidative phosphorylation (OXPHOS) are emerging as intriguing targets for the efficient elimination of cancer cells. The specificity of this approach is aided by the capacity of non-proliferating non-cancerous cells to withstand oxidative insult induced by OXPHOS inhibition. Recently we discovered that mitochondrial targeting can also be employed to eliminate senescent cells, where it breaks the interplay between OXPHOS and ATP transporters that appear important for the maintenance of mitochondrial morphology and viability in the senescent setting. Hence, mitochondria/OXPHOS directed pharmacological interventions show promise in several clinically-relevant scenarios that call for selective removal of cancer and senescent cells.
- 650 _2
- $a adenosindifosfát $x metabolismus $7 D000244
- 650 _2
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a buněčná smrt $7 D016923
- 650 _2
- $a proliferace buněk $7 D049109
- 650 12
- $a stárnutí buněk $7 D016922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a nádory $x metabolismus $x patologie $7 D009369
- 650 _2
- $a oxidativní fosforylace $7 D010085
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Magalhaes Novais, Silvia $u Molecular Therapy Group, Institute of Biotechnology, Czech Academy of Sciences, 252 50 Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Davidova, Eliska $u Molecular Therapy Group, Institute of Biotechnology, Czech Academy of Sciences, 252 50 Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Neuzil, Jiri $u Molecular Therapy Group, Institute of Biotechnology, Czech Academy of Sciences, 252 50 Vestec, Prague-West, Czech Republic. School of Medical Science, Griffith University, Southport 4222, Qld, Australia.
- 700 1_
- $a Rohlena, Jakub $u Molecular Therapy Group, Institute of Biotechnology, Czech Academy of Sciences, 252 50 Vestec, Prague-West, Czech Republic.
- 773 0_
- $w MED00005521 $t Biological chemistry $x 1437-4315 $g Roč. 400, č. 2 (2019), s. 141-148
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30281511 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113085110 $b ABA008
- 999 __
- $a ok $b bmc $g 1483478 $s 1083882
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 400 $c 2 $d 141-148 $e 20190128 $i 1437-4315 $m Biological chemistry $n Biol Chem $x MED00005521
- LZP __
- $a Pubmed-20200109